Guillermo Lerzo, MD

Articles by Guillermo Lerzo, MD

Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer

ByEduardo Richardet, MD, PhD,Cecilia Pedraza, MD,Elizabeth Mickiewicz, MD,Guillermo Lerzo, MD,Federico Coppola, MD,Alicia Elli, MD,Graciela Uranga, MD,Silvia Jovtis, MD,Mario Bruno, MD,Monica Ventriglia, MD,Maria Andrea Cuevas, MD,Ana Maria Alvarez, MD,Luis Alberto Suarez, MD,Luis Fein, MD

July 1st 1999

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may

Latest Updated Articles

Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer
Published: July 1st 1999 | Updated:

Guillermo Lerzo, MD

Articles by Guillermo Lerzo, MD

Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era

CRT Does Not Improve RFS/OS, Confers High-Grade Toxicity in Cervical Cancer

ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC

Zipalertinib Yields Early Activity in EGFR+ NSCLC CNS Metastasis Population

Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC